Takeda Pharmaceutical Posts Higher H1 Attributable Net Profit; Revenue Up

MT Newswires Live10-29 18:27

Takeda Pharmaceutical (TYO:4502) posted 305.63 billion yen in attributable net profit for the six months ended Sept. 30, compared with 112.44 billion yen a year ago.

EPS was 192.53 yen, compared with 71.57 yen a year earlier, according to a Tokyo Stock Exchange filing on Thursday.

For the period ended Sept. 30, revenue was 2.407 trillion yen versus 2.219 trillion yen previously, the biopharma company said.

The company declared a second quarter-end dividend of 102 yen, with payments starting Dec. 1.

For the fiscal year ending March 31, 2027, the company expects attributable profit of 209 billion yen, EPS of 131.28 yen, and revenue of 4.7 trillion yen.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment